Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects

Trial Profile

Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Aug 2015

At a glance

  • Drugs Rufinamide (Primary)
  • Indications Epilepsy; Lennox-Gastaut syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Aug 2015 Results published in the European Journal of Drug Metabolism and Pharmacokinetics.
    • 09 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top